RetractedArticleNeurology2022

Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus [RETIRED]: A Report of the AAN Guidelines Subcommittee.

Gregory S Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.